{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:39:53Z","timestamp":1791074393146,"version":"4.1.0"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,2,18]],"date-time":"2004-02-18T00:00:00Z","timestamp":1077062400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:title>Abstract:<\/jats:title><jats:p><jats:bold>Background\/Aims: <\/jats:bold> Antiproliferative action of tamoxifen in the estrogen receptor\u2010\u03b1\u2010negative human hepatoblastoma cell line HepG2 was investigated.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> HepG2 cells, seeded at different densities (4000\u201336\u2003000\u2003cells\/cm<jats:sup>2<\/jats:sup>), were incubated with tamoxifen (1, 10, or 20\u2003\u03bcM) or the telomerase inhibitor 3\u2032\u2010azido\u20103\u2032\u2010deoxythymidine (AZT) (0.6\u20133.0\u2003mM) up to 72\u2003h. Cell viability was assessed (MTT\u2010test), flow cytometric analysis was performed, and telomerase activity was measured (telomeric repeat amplification protocol assay).<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Ten or 20\u2003\u03bcM tamoxifen induced a reduction of cell viability. Basically reduction of viability was related to an increase in the fraction of G0\/1\u2010phase. When tamoxifen was present at higher concentration (20\u2003\u03bcM) or at low cell density (4000\/cm<jats:sup>2<\/jats:sup>) an additional increase of the rate of apoptotic cells occurred with a delay, aggravating the effect of tamoxifen on cell viability substantially. When apoptosis was induced a significant suppression of telomerase activity preceded regularly. Direct inhibition of telomerase activity with AZT resulted in a decrease of cell viability and apoptotis.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> The tamoxifen\u2010induced reduction of cell viability in HepG2 cells depends on drug concentration and cell density and is due to cytostatic and cytocide effects. The latter may be mediated by a down\u2010regulation of telomerase activity.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2004.00887.x","type":"journal-article","created":{"date-parts":[[2004,2,18]],"date-time":"2004-02-18T16:37:32Z","timestamp":1077122252000},"page":"46-54","source":"Crossref","is-referenced-by-count":26,"title":["Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down\u2010regulation of telomerase activity"],"prefix":"10.1111","volume":"24","author":[{"given":"Sebastian","family":"Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus\u2010Dieter","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Grote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,2,18]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"165","article-title":"Tamoxifen for the treatment of malignancies other than breast and endomerial carcinoma","volume":"24","author":"Gelmann E.","year":"1997","journal-title":"Semin Oncol"},{"key":"e_1_2_5_3_2","first-page":"66","article-title":"Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma","volume":"26","author":"Elba S","year":"1994","journal-title":"Ital J Gastroenterol"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80138-2"},{"key":"e_1_2_5_5_2","first-page":"543","article-title":"High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian gold hamster fed alpha\u2010naphtoflavone","volume":"73","author":"Li J J","year":"1984","journal-title":"a new tumor model"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80036-4"},{"key":"e_1_2_5_7_2","first-page":"498","article-title":"Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma","volume":"55","author":"Villa E","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/gast.1996.v111.agast961110271b","article-title":"Variant liver estrogen receptors and response to tamoxifen (letter)","volume":"111","author":"Villa E","journal-title":"Gastroenterology"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80038-7"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012437607881"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(99)00284-0"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400717"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(97)00594-7"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.10114"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/345458a0"},{"key":"e_1_2_5_16_2","first-page":"1496","article-title":"Principle of marginotomy in template synthesis of polynucleotides","volume":"201","author":"Olovnikov A M.","year":"1971","journal-title":"Dokl Akad Nauk (SSSR)"},{"key":"e_1_2_5_17_2","first-page":"181","article-title":"A theory of marginotomy","volume":"41","author":"Olovnikov A M.","year":"1973","journal-title":"the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomen"},{"key":"e_1_2_5_18_2","first-page":"3088","article-title":"Reversible cellulare senescence","volume":"9","author":"Wright W E","year":"1989","journal-title":"implications for immortalization of normal human diploid fibroblasts"},{"key":"e_1_2_5_19_2","first-page":"629","article-title":"Checkpoints","volume":"246","author":"Hartwell L H","year":"1989","journal-title":"controls that ensure the order of cell cycle events"},{"key":"e_1_2_5_20_2","first-page":"1129","article-title":"Replicative senescence","volume":"249","author":"Goldstein S.","year":"1990","journal-title":"the human fibroblast comes of age"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90008-Y"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05245.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199601000-00012"},{"key":"e_1_2_5_24_2","first-page":"3205","article-title":"The effects of telomerase inhibitors on lymphocyte function","volume":"19","author":"Beltz L","year":"1999","journal-title":"Anticancer Res"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.25.14276"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.18.2388"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.11.7264"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2184.1999.3250289.x"},{"key":"e_1_2_5_29_2","first-page":"2971","article-title":"Tamoxifen\u2010induced apoptosis in breast cancer cells relates to down\u2010regulation of bcl\u20102, but not bax and bcl\u2010X(L), without alteration of p53 protein levels","volume":"5","author":"Zhang G J","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_30_2","first-page":"5995","article-title":"Activation of caspase\u20103 and c\u2010jun NH2\u2010terminal kinase\u20101 signaling pathways in tamoxifen\u2010induced apoptosis of human breast cancer cells","volume":"60","author":"Mandleker S","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_5_31_2","first-page":"503","article-title":"hTERT can function with rabbit telomerase RNA","volume":"278","author":"Xiang H","year":"2000","journal-title":"regulation of gene expression and attenuation of apoptosis"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.23.13504"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.15.2091"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1523::AID-CNCR13>3.0.CO;2-P"},{"key":"e_1_2_5_35_2","first-page":"725","article-title":"Use of tamoxifen in hepatocellular carcinoma","volume":"15","author":"Tan C K","year":"2000","journal-title":"a review and paradigm shift"},{"key":"e_1_2_5_36_2","first-page":"1409","article-title":"Estrogen receptor\u2010mediated and cytotoxic effects of the antiestrogens tamoxifen and 4\u2010hydroxytamoxifen","volume":"44","author":"Taylor C M","year":"1984","journal-title":"Cancer Res"},{"key":"e_1_2_5_37_2","first-page":"4837","article-title":"Distribution of tamoxifen and its metabolites in rat and human tissues during steady\u2010state treatment","volume":"51","author":"Lien E A","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_5_38_2","first-page":"6","article-title":"Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubizin or vincristine","volume":"31","author":"Kobayashi H","year":"1992","journal-title":"mechanism of inoculum effects"},{"key":"e_1_2_5_39_2","first-page":"761","article-title":"Computational model of intracellular pharmacokinetics of paclitaxel","volume":"293","author":"Kuh H J","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199711000-00002"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.agast961110272"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01221192"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303498"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205463"},{"key":"e_1_2_5_45_2","first-page":"610","article-title":"Telomerase activity in human endometrium","volume":"57","author":"Kyo S.","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.13.6476"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2004.00887.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2004.00887.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:23:28Z","timestamp":1697297008000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2004.00887.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1111\/j.1478-3231.2004.00887.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2004.00887.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}